Figure 1.
Flow chart showing the two study populations.
Table 1.
Total number of women with negative cervical biopsy and later histologically confirmed CIN2+ by cytological result of post-colposcopy cytology.
Table 2.
Outcome for the 328 women in the cytology only group if triaged with post colposcopy cytology when cut-off is ASC-US+.
Table 3.
Outcome for the 328 women in the cytology only group if triaged with post-colposcopy cytology when cut-off is ASC-H+.
Figure 2.
The detection rate of CIN2+ in follow-up of women with negative cervical biopsy by HPV mRNA positive/negative versus cytology abnormal/normal.
Table 4.
Outcome for the 192 women in the HPV group if triaged by post-colposcopy HPV mRNA only.
Table 5.
Outcome for the 192 women in the HPV group if triaged by post-colposcopy HPV mRNA combined with cytology when cut-off is ASC-US+.
Table 6.
Outcome for the 192 women in the HPV group if triaged with post-colposcopy HPV mRNA combined with cytology when cut-off is ASC-H+.
Table 7.
Diagnosis of the first cervical biopsy compared to the most severe histological diagnosis.
Table 8.
Outcome for the 97 women under 40 years and the 95 women above 40 years in the HPV group if triaged with post-colposcopy HPV mRNA only.